Mirabella Financial Services LLP Raises Stock Position in The Beauty Health Company $SKIN

Mirabella Financial Services LLP boosted its holdings in The Beauty Health Company (NASDAQ:SKIN) by 21.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 15,596,277 shares of the company’s stock after buying an additional 2,734,728 shares during the period. Beauty Health makes up about 1.0% of Mirabella Financial Services LLP’s investment portfolio, making the stock its 9th biggest position. Mirabella Financial Services LLP owned approximately 12.23% of Beauty Health worth $31,037,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Franklin Resources Inc. acquired a new position in Beauty Health during the third quarter valued at approximately $31,000. Zacks Investment Management acquired a new stake in Beauty Health in the third quarter worth $35,000. Ameriprise Financial Inc. bought a new position in shares of Beauty Health during the third quarter worth $38,000. AQR Capital Management LLC acquired a new position in shares of Beauty Health in the 1st quarter valued at $40,000. Finally, ProShare Advisors LLC grew its holdings in shares of Beauty Health by 45.5% in the 2nd quarter. ProShare Advisors LLC now owns 23,447 shares of the company’s stock valued at $45,000 after buying an additional 7,336 shares during the period. Institutional investors and hedge funds own 93.26% of the company’s stock.

Beauty Health Stock Performance

Beauty Health stock opened at $1.20 on Tuesday. The business has a 50 day moving average of $1.27 and a 200-day moving average of $1.50. The company has a market capitalization of $152.36 million, a P/E ratio of -5.97 and a beta of 1.20. The Beauty Health Company has a 1 year low of $0.78 and a 1 year high of $2.69. The company has a debt-to-equity ratio of 3.94, a current ratio of 1.66 and a quick ratio of 1.40.

Beauty Health (NASDAQ:SKIN) last posted its earnings results on Thursday, March 12th. The company reported ($0.06) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.01. Beauty Health had a negative net margin of 3.16% and a negative return on equity of 15.40%. The firm had revenue of $82.37 million for the quarter, compared to analyst estimates of $78.07 million. On average, equities research analysts predict that The Beauty Health Company will post -0.25 earnings per share for the current year.

Analyst Ratings Changes

SKIN has been the subject of several research analyst reports. Canaccord Genuity Group reiterated a “hold” rating and issued a $1.50 price target on shares of Beauty Health in a report on Friday. TD Cowen dropped their target price on Beauty Health from $1.65 to $1.50 and set a “hold” rating on the stock in a research report on Monday. Zacks Research cut Beauty Health from a “hold” rating to a “strong sell” rating in a research note on Wednesday, January 21st. Jefferies Financial Group reaffirmed a “hold” rating and issued a $1.60 price objective on shares of Beauty Health in a research report on Wednesday, January 14th. Finally, Benchmark restated a “hold” rating on shares of Beauty Health in a research note on Friday. One analyst has rated the stock with a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Reduce” and an average price target of $2.42.

Beauty Health Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.